References

1.      Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM, März W. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets  2011 ;12:88-96

2.      Wang  L. Song Y, Manson JE, et al. Circulating 25-hydroxyvitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5:819-829.

3.      Anderson JL, May HT, Horne BD,Bair TL, Hall NL,Carlquist JF, Lappé DL, Muhlestein JB. Intermountain Heart Collaborative (IHC) Study Group. Relat-ion of vitamin D deficiency to cardio-vascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol.  2010;106:963-968.

4.      Sun Q, Pan A,  Hu FB, Manson JE, Rexrode KM. 25-hydroxyvitamin D levels and risk of stroke : a prospective study and meta-analysis. Stroke 2012;43: 1470-7 

5.      Wang  Y, Ji  H, Tong Y etal., (2014) Prognostic value of serum 25-hydroxyvitamin D in patients with stroke. Neurochem Res 39:1332-1337

6.      Gupta A, Prabhakar S, Modi M, Bhadada S K,, Lal V, Khurana D. Vitamin D status and risk of ischemic stroke in North Indian patients. Indian Journal of Endocrinology and Metabolism .Sep-Oct 2014; Vol.18, Iss.5:721-5

7.      Mitsuhashi T, Morris RC JR, Ives HE (1991) 1,25-Dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 87: 1889-1895.

8.      Wang TJ, Pencina MJ, Booth SL,etal. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.

9.      Rigby WF, Denome S, Fanger MW. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger rna. J ClinInvest  1987;79:1659-1664.

10.  Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenecity in mice. J BiolChem 2004; 279: 35798-35802.

11.  Michos  ED, and Gottesman RF. Vitamin D for the prevention of stroke incidence and disability: Promising but too early for prime-time. Eur J Neurol. 2013 January; 20 (1):3-4.

12.  Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke  patients- a randomized contro-lled trial. Nutr Metab Cardiovasc Dis 2012;22:864-70.

13.  Pokharel  BR, Kharel G, Thapa LJ, Rana PVS. Vitamin D and other risk factors among stroke patients. Kathmandu Univ Med J 2015;49(1):71-3

14.  Thapa   L, Shrestha A, Pradhan M, Bhandari T R, Shrestha S, Poudel RS, Pokhrel B, Poudel R. Status of vitamin D and its association with stroke risk factors in patients with acute ischemic stroke in a tertiary carte hospital. J Nepal Med Assoc  2014;52(195):935-39.

15.  Kojima  G, Bell C, Abbott RD, Launer L, Chen R, Motonaga H, etal.Low  dietary vitamin D predicts 34-year incident stroke: the Honolulu Heart Program. Stroke 2012; 43:2163-7

16.  Kikkinen  A, Knert P, Aro A, Rissanen H, Marniemi J, Heliövaara M, Impivaara O, Reunanen A. Vitamin D status and the risk of cardiovascular  disease death.  Am J Epidemiol 2009;170:1032-1039.

17.  Chatterjee  K, Mandal SK, Chatterjee S, Sarkar P, Mondal SS, Ganguly J, Sardar D, Mani S, Das B. Assesment of vitamin D in cerebrovascular accident patients in Eastern India. National Journal of Medical Research , vol.4,iss. 4, Oct-Dec 2014;264-269  

18.  Marcén  R, Jimenez S, Fernández-Rodriguez A,Galeano C, Villafruela JJ, Gomis A, etal. Are low levels of 25-hydroxyvitamin D a risk factor for cardiovascular disease or malignancies in renal transplantation. Nephrol Dial Transplant 2012 ; 27(Suppl 4): iv47-52

19.  Kühn T, Kaaks  R, Teucher B, Hirche F, Dierkes J, Weikert C, Katzke V, Boeing H, Stangl GI, Buijsse B  (2013) Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)- Germany study. PloS ONE 8:e69080. 

20.  Burgaz A, Orsini N, Larson SC,Wolk A (2011) Bood 25-hydroxyvitamin D concenteration and hypertension: a meta-analysis. J Hypertens29:636-645 

21.  Tamez H and Thadhani RI. Vitamin D and hypertension: an update and review. CurrOpin Nephrol Hypertens 2012; 21:492-9

22.  Scragg  R, Wishart J, Stewart A, Ofanoa  M, Kerse N, Dyall L, etal. No effect of ultraviolet radiation on blood pressure and other  cardiovascular risk factors . J Hypertens  2011;29:1749.

23.  Afzal  S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and meta-analysis. Clin Chem. 2013;59:381-391.

24.  Song  Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, Hu FB ( 2013) Blood 25-hydroxyvitamin D levels and incident type 2 diabetes: a meta-anlysis of prospective studies. Diabetes Care 36: 1422-1428.

25.  Kazlauskaite  R, Powell LH, Mandapakal C, Cursio JF, Avery EF,Calvin J. Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women. J ClinLipidol 2010;4:113-119.

26.  Zittermann A, Gummert JF, Börgermann J. The role of vitamin D in dyslipidemia and cardiovascular disease.Curr Pharm Des 2011; 17: 933-42.

27.  Ponda  MP, Huang X,Odeh MA, Breslow JL, Kaufman HW (2012) Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 126: 270-277.

28.  Wang H, Xia N, Yang Y, Peng DQ (2012) Influence of vitamin D supplementation on plasma lipid profile: a meta-analysis of randomized controlled trials. Lipids Health Dis 11:42.

29.  van BallegooijenAJ,ReindersI,Visser M, Dekker JM, Nijpels G, Stehouwer CD, Pilz S, Brouwer IA (2013)  Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: the Hoorn study. J ClinEndocinolMetab 98: E638-E645.

30.  vanBallegooijenAJ,ReindersI,Visser M, Brouwer IA (2013 )  Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am Heart J 165: 655-664.

31.  Pilz  S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. MolNutr Food Res 2010; 54 :1103-13

32.  Pilz S, Gaksch M., O'Hartaigh B, Tomaschitz A, März W. The role of vitamin D deficiency in cardiovascular disease: where do we stand in  2013? Arch Toxicol (2013) 87: 2083-2103.

33.  Park  K Y, Chung PW, Kim YB, Moon HS, Suh BC, Won YS, Kim JM, Youn YC, Kwon OS . Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke.Cerebrovasc Dis 2015;40:73-80 

34.  TuWJ,ZhaoSJ,Xu  DJ etal (2014) Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischemic stroke. ClinSci 126(5) :339-346

35.  Daubail  B, Jacquin A, Guiland  JC, Khoumri C, Aboa-Eboulé C, Giroud M, Béjot Y: Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc Dis 2014 ; 37:364-367

36.  Chaudhuri JR, Mridula KR, Alladi S, Anamika A, Umamahesh M, Balaraju B, Swath A, Bandaru VS. Serum 25-hydroxyvitamin D deficiency in  ischemic stroke and subtypes in Indian patients. J Stroke 2014; 16:44-50 

37.  Bakradze  E, McCullough L, Staff I, Nouh A (2016)Vitamin D deficiency correlates with stroke severity on presentation in intracerebral hemorrhage. Stroke; Feb., Vol.47,Iss. Supp 1

38.  Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S (2012). Vitamin D deificiency and mortality risk in the general population: a meta- analysis of prospective cohort studies. Am J ClinNutr 95:91-100..

39.  GiovannucciE,LiuY,Hollis BW, Rinm EB. 25-hydroxyvitamin D and risk of myocardial  infarction in men. Arch Intern Med. 2008:168:1174-1180.

40.  Allison M, His S, Wassel C, Morgan C,   Joachin H, Wright C, etal. Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler ThrombVascBiol,  2012 ; 32:140-6

41.  Touboul PJ, Grobbee DE, RuijterHD. Assesment of subclinical atherosclerosis by carotid intima media thickness: technical issues. European Journal of preventive Cardiology,  2012;19(2):8-24 

42.  Giri R, Rai R, Verma S, Verma RK .Correlation between vitamin D and carotid artery intima media thickness  in patients with ischemic stroke. Iternational J of Advances in Medicine ,April-june  2016, Vol 3,Issue 2;398-393.

43.  Carreli A L, Walker  M D, Lowe H, McMahon D J, Rundek T, Sacco RL and Silverberg S J. Vitamin D deficiency is associated with subclinical  carotid atherosclerosis: The Northern Manhatten study . Stroke, 2011;42:2240-2245.

44.  Blondon M, Sachs M, Hoofnagle AN, TX JH, Michos ED, KorcarzC,etal. 25-hydroxyvitamin D and parathyroid hormone are not associated with carotid intima- media thickness. Arteioscler Thromb VascBiol, 2013;33 (11):2639-45.

45.  Sachs  MC, Brunzell JD , Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Zinman B,  de Boer IH. Diabetes control and complication Tria/Epidemiology of Diabetes Interven-sions and Complications Study (DCCT/EDIC) Research Group ( 2013 ) Circulating vitamin D metabolites and subclinical atherosclerosis in type ӏ diabetes. Diabetes Care 36:2423-2429.  

46.  Akio Nakashima, Keitaro Yokoyama, Takashi Yokoo, Mitsuyoshi Urashima : Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes 2016 March 10; 7(5): 89-100.

47.  V Majumdar, P Prabhakar, GB Kulkarni and R Christopher : Vitamin D status, hypertension and ischemic stroke: a clinical perspective.  Journal of Human Hypertension (2015) 29, 669–674.

Corresponding Author

Effat A E.Tony

Internal Medicine, Assuit University